Chen Su
1095 Jiefang Avenue
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
The multifaceted roles of the ACSL family in cancer: Metabolic reprogramming, ferroptosis regulation and tumour immune microenvironment remodelling.
Journal: Clinical and translational medicine
Published: January 06, 2026
m6A-Mediated TMCO3 Promotes Hepatocellular Carcinoma Progression by Facilitating the Membrane Translocation and Activation of AKT.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 07, 2025
NEK7-induced phosphorylation of EGFR on serine 1070 drives the acquired lenvatinib resistance in hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: January 09, 2025
Targeting FAM134B-DDX3X axis inhibiting AKT signaling in hepatocellular carcinoma.
Journal: Cell death & disease
Published: November 24, 2024
m6A-Dependent ITIH1 Regulated by TGF-β Acts as a Target for Hepatocellular Carcinoma Progression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 27, 2024
SP1-activated USP27X-AS1 promotes hepatocellular carcinoma progression via USP7-mediated AKT stabilisation.
Journal: Clinical and translational medicine
Published: September 08, 2023
Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets.
Journal: Cell communication and signaling : CCS
Published: August 23, 2023
ALKBH5-mediated m6A modification of lincRNA LINC02551 enhances the stability of DDX24 to promote hepatocellular carcinoma growth and metastasis.
Journal: Cell death & disease
Published: August 10, 2022
α-Connexin Carboxyl Terminal Peptide 1 Attenuates Ischemia-Reperfusion Injury in Liver Transplantation With Extended Cold Preservation by Stabilizing Cell Junctions in Mice.
Journal: Transplantation proceedings
Published: June 30, 2022
Last Updated: 09/26/2026